Merck's product recalls
3 official recall notices between Aug 2025 and Dec 2025 were matched to Merck.
Each notice concerns the specific products, sizes and lot codes it names. A recall does not mean that other Merck products are affected, and a count of notices is not a measure of safety: one incident can produce a notice for every pack size.
Covers only notices from the U.S. Food and Drug Administration enforcement reports (openFDA), USDA Food Safety and Inspection Service recalls, UK Food Standards Agency food alerts and U.S. Consumer Product Safety Commission recalls that could be matched to Merck: the recalling firm must be Merck, a parent or a subsidiary, and for a brand the brand name must appear in the product description. Method.
2025 (3)
| Date | Product | Brand | Recalling firm | Reason given | Source |
|---|---|---|---|---|---|
| Merck Emend (aprepitant) for oral suspension, 125 mg, Single-Dose Kit, Rx Only, Manufactured for: Merck Sharpe & Dohme LLC, Rahway, NJ 07065, USA,… | — | Merck Sharp & Dohme LLC | Presence of particulate matter: potential presence of metal particulates in the product. Class II | FDA | |
| Noxafil Powdermix (posaconazole) for Delayed-Release Oral Suspension, 300 mg, 8 packets per carton, Rx Only, Manufactured for: Merck Sharp & Doohme LLC,… | — | Merck Sharp & Dohme LLC | Presence of particulate matter: potential presence of metal particulates in the product. Class II | FDA | |
| Belsomra (suvorexant) tablets, 10mg, 30 Tablets in 3 Blister Cards per Carton, Each Blister Card contains 10 Tablets, Rx only, Merck Sharp & Dohme LLC,… | — | Merck & Co. Inc | Failed Dissolution Specifications: potential for delayed dissolution of the dose after administration which may result in delayed release… Class II | FDA |
Product descriptions and reasons are shortened from the regulators' own text; the linked notice is the authoritative record. See all matched recalls, or report a wrong match through the corrections page.